Patients Showed Symptomatic Relief in Phase I Trial of Glasdegib - 35% of Patients had at least a 20% improvement in their Symptom Burden - 101931

Spotlight
Video

Patients Showed Symptomatic Relief in Phase I Trial of Glasdegib - 35% of Patients had at least a 20% improvement in their Symptom Burden

ASHReport has 256 videos Subscribe Here

Loading........
Description: Aaron Gerds, MD from Cleveland Clinics discusses patients showed symptomatic relief in Phase I Trial of Glasdegib and 35% of patients had at least a 20% improvement in their symptom burden at the 2017 American Society of Hematology.
Shared By : ASHReport
Posted on : 01/26/18
Added : 4 months ago